Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03086265 · ClinicalTrials.gov registry record · NA

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Laser Laryngeal Surgery

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT03086265: Completed NA study, sponsored by Stanford University.

NCT03086265 is a NA study that has completed, run by Stanford University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03086265, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The purpose of this study is to investigate whether laser laryngeal surgery can be safely and potentially more effectively performed without the use of tracheal intubation or jet ventilation, under completely tubeless conditions. The patient's gas exchange will be supported by rapid insufflation of high-flow oxygen through specialized nasal cannula: the so called Transnasal Humidified Rapid- Insufflation Ventilatory Exchange (THRIVE).

Primary Outcome

Peripheral oxygen saturation is an estimate of the amount of oxygen in the blood.

Interventions

  • DEVICE Endotracheal tube
  • DEVICE THRIVE

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2017-03-24
Est. Completion 2019-02-26
Phase NA
Stanford University

1,744 total trials

What the finished NCT03086265 record still lists

NCT03086265 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Endotracheal tube is the first listed.

NCT03086265 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03086265 about?

NCT03086265 is a clinical study titled "Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Laser Laryngeal Surgery". The purpose of this study is to investigate whether laser laryngeal surgery can be safely and potentially more effectively performed without the use of tracheal intubation or jet ventilation, under completely tubeless conditions. The patient's gas exchange will be supported by rapid insufflation of ...

What is the current status of trial NCT03086265?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-03-24. Estimated completion is 2019-02-26.

What interventions are being tested in trial NCT03086265?

The interventions under investigation include: Endotracheal tube (DEVICE), THRIVE (DEVICE).

Who is sponsoring clinical trial NCT03086265?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03086265's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03086265, the US trial registry maintained by the National Library of Medicine. NCT03086265 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.